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SUMMARY OF PROGRESS  
During the past year the research activities have been divided equally 
between experimental and calculational efforts. However, progress in the 
calculational area has been made quickly and some valuable data have been 
obtained. Significant strides in the experimental area have been slow in 
coming. These efforts are discussed individually below. 
A. 	Absorbed Dose Distributions in Organs Constructed of PATE  
The PATE dosimetry system has been used to provide volume averaged absorbed 
dose estimates for comparison to Monte Carlo calculations using the 
Snyder-Fisher phantom. These data were reported previously (3). In 
addition, the PATE system has the potential for use in providing absorbed 
dose distributions in the internal organs of the body. These dose 
distributions are of special interest in some of the large organs, such as 
liver, and also in organs located near the "source" organ(s) where there is 
a strong inverse square dependence in the radiation field intensity. It is 
clear that a better understanding of radionsensitive cells in certain 
organs will require a better estimate of the absorbed dose to certain 
critical cells or regions in these organs. 
The PATE dosimetry system could be applied to this particular problem if a 
technique for sectioning the "organ dosimeters" could be developed. The 
technique must be relatively simple, easy to use, and must ensure that the 
TLD crystals incorporated in the tissue equivalent matrix are not 
thermally annealed during the sectioning (i.e., TLD crystals should not be 
heated to temperatures above about 100 °C). 
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At this point little progress has been made toward solving this problem. 
The PATE mixture was, by design, a relatively hard material which could be 
subjected to rugged handling during the experiments. Attempts to design a 
device to section the mixture have provided only limited success. 
Thermal cutting of the mixture was the first procedure tested. In all 
experiments the goal was to keep the bulk temperature of the PATE mixture 
below 100 °C (the temperature of the TLD pre-read anneal). 
Large organs could be cut easily with an electrically heated Nichrome wire. 
The wire, mounted on an insulated handle and heated to an appropriate 
temperature, could be passed easily through the organ. However, as the 
wire passed through the organ the "cut" made by the heated wire was quickly 
"healed" as the PATE system cooled rapidly to its solidification 
temperature (about 60 oC). The net result was an intact organ, and sections 
of any reasonable size have not been obtained. 
Modifications to this technique were tried to overcome the "healing" 
effect. For example, thin metal blades, electrically heated, were also 
tried in an effort to keep a larger area of the "cut" open at any one time. 
However, at this point, these attempts have not provided satisfactory 
results since the region continues to "heal" as the blade moves through the 
organ. 
It is clear that a large heated blade for sectioning the organ is the 
solution to this problem. 	However, since the organs have various shapes 
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and the sensitive regions of the organs do not necessarily have simple 
shapes, this apparent solution does not truly provide the needed 
flexibility. 
In other applications (see section B), the PATE system is sectioned into 
volumes of interest using a sharp knife. However, it is clear that this 
technique does not provide the kind of precision necessary for future work 
in this application nor in the extension to accurate extremity dosimetry. 
Discussion with the faculty and staff of the Schol of Mechanical 
Engineering may provide additional possibilities for study. 
Because of the lack of progress in this area, no experiments have been 
attempted inside the physical mock-up of the Snyder-Fisher phantom. 
B. 	Use of PATE System for Extremity Dosimetry  
The problem of obtaining accurate absorbed dose estimates for the 
extremities is a serious one and is still largely unresolved in routine 
personnel dosimetry (4,5,6). The particular difficulty with current 
techniques (finger and wrist dosimeters) is that the absorbed dose to the 
fingers, hands, and forearms must be estimated from point measurements 
supplied by these dosimeters. In addition, these dose estimates are 
complicated by the fact tht the radiation fields, for which the estimates 
are required, usually have very steep dose gradients due to the inverse 
square relation. For these reasons, measurements obtained with finger or 
wrist dosimeters may not be indicative of the actual absorbed dose. 
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The PATE dosimetry system developed previously in this research presents 
an excellent opportunity to attack the extremity problem from a different 
angle. PATE, molded in the shapes of hands, can be exposed in a number of 
typical situations. Total dose and dose distributions in the hands can be 
obtained. These data can be compared to results obtained with finger and 
wrist dosimeters. The goal of this research is to provide a set of data 
which can be used to correlate the absorbed dose to the extremities to the 
dose measured by typical dosimeters. 
During this year the primary effort has focused on molding techniques. 
However, some exposures, of an exploratory nature, have been made. 
Progress in this area is discussed below. 
Preparing molds of the human hands is more complicated than techniques 
developed previously for the organs of the physical phantom. These organs 
had regular shapes and molds could be prepared easily by wrapping models of 
the organs with strips of plaster-of-paris tape(7). A mold of the human 
hand should, ideally, include individual regions for the thumb and four 
fingers. At the same time, it should be rugged due to the anticipated use. 
Initial attempts to prepare a mold of the human hand used the plaster-of-
paris strips mentioned above. Rubber gloves (size 8) were filled initially 
with paraffin to produce a solid structure around which the plaster strips 
could be wrapped. A layer of plaster strips was laid down on the glove 
completely enclosing the hand. To provide additional strength, extra 
layers of the plaster strips were added in the area of the fingers. 
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Although each finger was clearly defined inside the mold, the outer surface 
of the mold resembled a large mitten. 
The mold was allowed to dry at room temperature on the laboratory bench. 
After the mold was dry and solid, a cast saw was used to remove it from the 
rubber glove-paraffin mold. Initial molds were quite fragile, primarily 
due to the need to have a realistic thumb, and other methods of molding 
were investigated. 
One simple technique was to use a disposable surgeon's glove as the mold. 
A wire rim was fabricated to support the glove and to hold it open at the 
top. The PATE mixture was poured into the open glove and the glove was 
immersed immediately in a cold water bath. The bath promoted rapid 
solidification of the outer surface of the PATE and the entire PATE hand 
was completely hardened in about 20 minutes. At this point the surgeon's 
glove could be removed easily, revealing a smooth PATE hand. 
However, several problems still remained. First, this simple procedure 
did not produce identical "hands" each time it was used. Second, the palm 
region of the hand was much too thick and was not truly representative of 
the human hand. Third, the fingers of the PATE hand nearly touched at the 
tips, another unrealistic situation. 
To solve these problems and to have some control over the actual shape of 
the PATE hand, the two methods discussed above were combined. 	The 
surgeon's glove was retained as the primary mold but a plaster-of- 
support was also prepared. The plaster support provided some structural 
rigidity in the region of the palm but did not cover any of the fingers. 
This combined technique provides a reproducible "hand", holds the fingers 
apart, and controls the thickness of the palm region. However, because of 
the use of plaster-of-paris, the water bath had to be abandoned. At this 
point the PATE mold is allowed to solidify overnight before use. 
Two test exposures have been made to date using the PATE hands. The first 
exposure used a single hand oriented perpendicular to a beam of Co-60 
gamma-rays. Distance from the source was 2.0 meters and the target 
exposure was 500 mR. The second exposure involved two hands oriented with 
the fingers of the hands pointing toward the source (i.e., the hands were 
oriented parallel to the beam). Again the distance from the source to the 
palms of the hands was 2.0 meters and the target exposure at the center of 
the palms was 500 mR. At this point, results are not available due to the 
large number of TLD samples that must be evaluated. 
A cooperative program has been established with the Centers for Disease 
Control in Atlanta. The PATE hand dosimeter will be used to evaluate the 
absorbed doses to the fingers and hands of persons wearing radioactive gold 
jewelry. 
The first reports on radioactive gold jewelry were published in the 
scientific literature in the late 1960's (8,9). The source of this 
radioactive gold is the use of spent radon seeds. Radon seeds, used for 
cancer therapy, are typically made of 24K gold. These seeds are tiny 
hollow rods (wall thickness 0.3 mm), 0.75 mm in diameter and about 4.0 mm 
in length. Each seed has a mass of about 0.03 grams. During clinical use 
each seed may contain between 0.05 and 5 mCi of Rn-222. Although the seeds 
are no longer clinically useful, due to the decay of the short-lived radon, 
the gold seeds remain radioactive for a much longer period. One of the 
radon decay products is Pb-212, which has a half-life of 22.3 years. 
It has been estimated that 100 to 200 gold seeds would be required to make 
a single gold wedding band (10). Dose rates to the basal layer of cells 
have been measured to be in the range 12 to 60 rads/day (8). 
The cooperative research in this area involves using the PATE hands and 
placing radioactive gold jewelry on the hands for known periods of time. 
The PATE system can provide estimates of the absorbed dose to individual 
fingers and, if sectioning techniques can be worked out, dose 
distributions and estimates of the absorbed dose to sensitive cell layers. 
This research is being pursued with the cooperation of Ms. Christine Eheman 
(CDC) and Dr. G. D. Schmidt (CDRH). One ring has been obtained for use and 
at least one more ring will be shipped later. Because of molding problems 
no data has been obtained so far. 
C. 	Development of a Realistic Head and Neck Region  
The Snyder-Fisher phantom was designed more than 16 years ago and, in many 
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ways, reflects not only the computer capability at the time but also the 
areas of interest in nuclear medicine. For example, a number of agents are 
now used for brain-scanning, a procedure used more sparingly many years 
ago. 	The present phantom cannot be used to provide meaningful dose 
estimates for many of the newer procedures. 	A major effort has been 
devoted to the development of a more realistic head for incorporation in 
the computer code used for internal dose calculations. The realistic head 
for a 10-year old, proposed by Deus and Poston (11), was used as the model. 
Assumptions  
In the design of a more realistic head and neck region for the adult 
phantom, the following assumptions were made: 
1. The total mass of the head and neck given by Snyder et al. (12) 
represents a realistic value and will be used as a target in the 
design. 
2. The neck region represents about 1/8th of the total volume (and 
mass) of the region and the remaining 7/8ths is assigned to the 
head region. 
These assumptions lead to the conclusion that the head and neck combined 
should have a total mass of 5083 g and a volume of 4655 cm
3
. Based on 
assumption 2, the design masses and volumes of the head and neck can be 
established. For the head, the design values are 4483 g and 4095 cm
3
. For 
the neck, the design values are 600 g and 560 cm
3
. 
3. The dimensions of the various sections of the head may be 
obtained from ICRP 23(13) or through use of proportionalities 
with those of the ten-year old (11). 
4. The heights of the head, trunk, and leg regions (i.e., the 
dimensions in the z-direction) in the the Snyder-Fisher phantom 
are correct and should not be modified in this design. 
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The phantom, as in previous discussions, is assumed to be erect and 
oriented in a Cartesian coordinate system. The origin of the coordinate 
system is taken as the center of the base of the trunk, the positive x-
axis is directed to the phantom's left, the positive y-axis toward the 
posterior of the phantom, and the positive z-axis upwards through the head. 
Description of Head and Neck Regions  
Computer plots of the head and neck regions are shown in Appendix I and II 
for the y,z-plane and x,y-plane, respectively. Descriptions of the 
individual sections and components are given below: 
Head region: The head region is a right elliptical cylinder topped by half 
an ellipsoid. The elliptical cylinder is cut by an inclined plane at the 
back of the head so the bottom base of the cylinder coincides with the top 
of the neck. For example, see the y,z plot with x=0 in Appendix I. 
For 75.0 4 z` 88, 
x 
2 + 	y .) 2 _4 1 
.94) 	10 
If y <5, then 
x 
2 + ( y )2 	
0.0336538462z-1.96154 - (z-8 8 	4  
(.94) 	10 	 405.003772 
For 88 4 z 4 94, 
2 
x 	+ ( y )2 +(z-88y 4 1 
(7. 9Z). 10 	6 
The head has a volume of 4083.9 cm
3 
and a mass of 4507.3 g. 
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Neck region: The neck region is composed of tissue, thyroid, bone (part of 
the spine), and skin (2 mm thick). This region is represented by a 
circular cylinder given by: 





 - 6.01 
The volume of the neck is 567.37 cm3 and it has a mass of 588.3 g. 
Bone region: 	Regions containing bones include the cranuim, face, 
mandible, lower and upper teeth, and the spine. Each of these is described 
below: 
Cranium: The cranium is the volume between concentric ellipsoids cut by 
two inclined planes. The external shell is composed of two half ellipsoids 
having the same parameters along the x- and y-axes but different parameters 
along the z-axis. The internal shell is separated by a distance of 6.2 mm 
from the external shell. The volume of the cranium is 421.7 cm 3 and the 
mass is 626.7 g. 
The external ellipsoids are given by: 
88 15 z -4 93.8 
(
x:) 2 +(y  2 + (z - 88 2 .5- 1 
7.74 	9.8 	5.8 
81.1 #- z 	88 
x 2 + y 2 + 	z - 88 2 5 1 
(7.74) 	9.8 6.9 
and if y 4 o, then 
z 2" 81.1 -(6.9y 







+t z - 88) 2 
k\  9.18 	5.18 
81.1` z 	88 
(7 x 2 "F( 	+(z  .12 	9.18 	6.28 
if y 5 o, then 
z ?I' 81.72 -(6.9)y 
9.8 
Face: The face of the phantom is divided into two regions; the upper face 
(excluding the eyes and nares) and the upper teeth region. 
The upper face region is described by a solid elliptical cylinder cut by an 
inclined plane, which defines the cranium, and vertical and horizontal 
planes, which separate the upper face region from the mandible and the 
upper teeth region, respectively. The equations defining this region are: 
80` z -4 88 




If 	x 2 +  y  2 + z - 88 2 1, 
.74 	9.8 	6.9 7  
then z 	81.1 - (6.9)y 
9.8 
The eyes and the nares are excluded from the region and are described by 
the following equations: 
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The eyes are assumed to be spheres 
(x - 3.4) 2 	(y 	7.5) 2 
+ (z - 84.2)`` (1.22) 2 
Both eyes have a volume of 15.2 cm
3 
and a total mass of 15 g. 
Nasal regions: 	The nasal regions are defined by two half-horizontal 
elliptical cylinders oriented perpendicular to the x-axis. The cylinders 
are cut by the surface which defines the face region and the vertical plane 
which separates the face region from the mandible. The equations are: 
	
(
Ix1 - 0.21) 2 + 	- 82 2 	1 
0.80 	 1.7 	
with Ix' ?' 0.21, 
- 9.6 [1 - 	4 2 	y 	- 4.05 
The nasal regions have a volume of 24.3 cm3 and a mass of 24 g. 
If the eyes and the nasal regions are excluded, the upper face region has a 
volume of 241.9 cm
3 
and a mass of 359.5 g. 
Upper Teeth Region: This region is assumed to be the volume between two 
concentric elliptical cylinders cut by three planes: two horizontal 
planes which define the boundaries of the bone region of the face and the 
lower teeth and one vertical plane which defines the mandible. The 
defining equations for this region are given by: 
2 




2 	 2 , 
+(y, + 4.05) - 1 
(3.44) 	4.70 
y 	- 4.05 
78.72 	z -4 80 
The volume of the upper teeth region is 15.6 cm 3  with a mass of 23.2 g. 
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Mandible: The mandible is divided into two parts: the region of the lower 
teeth and the remainder of the region. 
The lower teeth region is similar to that for the upper teeth. This region 
is described as the volume between two concentric cylinders cut by three 
planes: two horizontal and one vertical. The defining equations are: 
y + 4.05) 2 `1  - 1
	
.60 	5.20 
+(y + 4.05) 2 `1 1
(3.44 	4.70 
y 4 - 4.05 
77.44 4 z 4 78.72 
The lower teeth region has a volume of 15.6 cm 3 and a mass of 23.2 g. 
The region excluding the lower teeth is assumed to be the volume between 
three elliptical cylinders cut by two vertical planes (defined by y = o and 
y = - 4.05), two inclined planes, and one horizontal plane. The equations 
defining this region are: 
7 	x:) 2 
6.40 
+(y\ 	+ 4.0) 2 4 1 
5.55 






for y 	- 4.05 and 0.0625 y + 75.80 4 z 	77.44, and 
(6.40
x 	+(y + 4.0.0 -4 1 
5.55 
(
x 2 + ( \2 	1 
 4.20) 	\7.80i 
for - 4.05 4 y 	o and 0.0625 y + 75.80 4 z 	81.1 - 76.9 
\9.8 
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The volume of this region (excluding the lower teeth) is 183.5 cm 3 
corresponding to a mass of 272.7 g. 
Spine: The spine is represented by an elliptical cylinder bounded by the 
external ellipsoid which defines the cranium. The equations are: 
75 	fr 88 - 6.9[ 1 f x ) 2 
\7.74 
1.67 
x) 2 +(y - 3.7  
The volume of the spine is 134 cm3 and its mass in 199 g. 
Organs: In addition to the eyes and the nasal regions, two organs are 
defined. These are the brain and the thyroid gland. 
The brain is contained in the inner shell of the cranium. It is described 
following the model proposed by Eckerman et al. (14) and consists of two 
regions: one region made of white matter and a second region consisting of 
a mixture of gray and white matter. The white matter region is 13% by 
weight of the total brain, whereas the mixed region contains 49% by weight 
gray matter and 37.2% by weight of white matter. The brain is represented 
by two half-ellipsoids, the lower half-ellipsoid cut by an inclined plane 
(see cranium). The white matter is defined by a centered ellipsoid divided 
into two hemispheres by a plane. The remainder is assumed to be composed 
of white and gray matter. 
21 i 
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y 	+ (z - 88)2 	1 
9.18 6.28 07 .12 x 
2 
white matter region: 
(
x \2 ( 	
+ /z - 88 2 	1 
4.42) 	6.48 	\2.48 
where -1.35 	x 	1.35. The volume of the white matter is 200.9 
3 cm with a mass of 198.3 g. 
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9.18 5.18 
and for z - 88, 
For this region, the volume defining the white matter is excluded. The 
volume of the gray and white matter region is 1266.1 cm
3 and the mass is 
1249.5 g. The total volume of the brain is 1467 cm
3 and the mass is 
1447.7g. 
Thyroid gland: The lobes of the thyroid are represented as the volumes 









2 + (y + 0.8)
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 - 1 
y + 0.80 	0 
70` z -4 74.75 
[(y + 0.80) - i
x 	z (x2 + (y + 0.80) 2 )Z 2 
with Z = 2( VT- 2) (z - 70) + 1 for 0 	z - 70 	71.25 
4.75 
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and r = 2(2 -V-1) (z - 70) + 2 i + 1 for 1.25 	z - 70 	4.75 
14.25 	 3 
The volume of the thyroid gland is 19.9 cm
3 
and the mass is 19.6 g. 
Table 1 summarizes the volumes and masses of the organs and regions in this 
new design. Table 2 gives a comparison of the old and new regions. As 
stated previously, computer plots of the regions are given in Appendices I 
and II. 
At this point, this new design is being coded into the existing Monte Carlo 
code. After debugging the modified code, it is anticipated that computer 
calculations will be undertaken for a large number of radionuclides. At 
this time, it is not clear that the calculations will be completed by the 
end of the project year (i.e., July 31, 1984). 
D. 	Development of a Model of the Circulating Blood  
Currently, the MIRD Committee of The Society of Nuclear Medicine has a 
great need for a model to describe the circulatory system in an adult human 
(15). This need exists because of the large number of radionuclides used 
in nuclear medicine which have short half-lives and only irradiate the body 
as they are carried throughout the body in the circulatory system. In 
addition, no model is available at present which describes concentrations 
of radionuclides in regions, such as the "face", which are fed primarily 
from the blood pool. 
During this period a significant effort has been directed toward the 
development of a simple model of the circulating blood. 
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Description of the Blood Model  
Initial data, on which the model was based, were selected from the Report 
on Reference Man (13). A total blood volume of 5200 ml was selected as 
being appropriate for a 70 kg adult. Table 3 gives the distribution of the 
blood in the total body based on this blood volume. Table 4 shows a more 
extensive breakdown on the blood distribution in the adult. The total 
volume obtained from this table ranges between 5103 and 5437 ml and, 
therefore, the 5200 ml value selected for the model is in apparent 
agreement with these data. 
The Report on Reference Man (13) also presented data on the total blood 
volume in most organs of the body. These data were used to select those 
organs which should be included explicitly in the model. In addition, 
these data provided important guidance on those organs or regions of the 
body which could be combined into a single region in the model. Organs 
included in the blood model were the brain, heart, kidneys, liver, lungs 
and the spleen. Special regions, created for use in the simplified model, 
included the extremities, face, intestinal, aorta and vena cava, and the 
"remainder". Table 5 gives the total blood volume assumed to be in each 
organ or region of the model. 
The organs named specifically in Table 5 are described mathematically by 
equations which were already part of the existing computer code. All other 
regions were designed especially for use in the model of the circulating 
blood. A short description of each of these regions is given below. 
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Extremities: 	The extremities are right circular cylinders, 1 cm. in 
diameter, located on the inside of the existing arm and leg bones. For 
example, the arm region lies between the existing arm bone and the ribs. 
It runs parallel to the bone region. Each arm region had a length of 69 cm. 
while each leg region was 79.8 cm. in length. The arm regions were moved 
forward 2.5 cm. along the y-axis to eliminate overlapping with the ribs. 
Arm regions: [ x + (17.9-0.02029)] 2 + (y+2.5) 2 .-- 0.5 
0 ': z 	69. 
The + and - correspond to the right and left arm regions, respectively. 
Leg regions: 	x + (6 + 0.06892z) 2 + y2 14- 0.5 
- 79.8 '5- z '" 0. 
Face region: The face region was assumed to be a region on the lower two-
thirds of the head (i.e., z - 85.5). This region was formed by a plane 
which cut vertically through the elliptical cylinder of the head at y = -7. 
Care was taken in the definition of the face region to assure that there 
was no overlap between this region and the brain, another source organ. 
-5 <.. x <5 
-7 < y < 0 








Lc 	+ X + 	(z - 86.5) 2 -,,. 1. 
6 9 6.5 
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The last equation excludes the brain from the face region. 
Intestinal Region: The intestinal region was assumed to be located in the 
lower trunk constrained between z = 0 and z = 27. For simplicity the 
region was assumed to be represented by an elliptical cylinder with 
essentially the same dimensions as the trunk. However, the skin was not 
included in this region. The major axis of the elliptical cylinder was 
assumed to be 19.8 cm. and the minor axis was 9.8 cm. The center of this 
region, a circular region with the same height and a radius of 2.5 cm., was 
removed to bring the volume in line with the design parameters. Care was 
also taken that the intestinal region did not overlap with the aorta and 
vena cava region. 
-x2 + y 2 	2.5 
(19.6 	9 8 
_Y_ 
0 4 Z z- 27. 
Aorta and Vena Cava: 	This region was described by a right circular 
cylinder with a radius of 2.5 cm. located between z = 8 and z = 44.8. Care 







x + _/ - z 	-1 
35 	45 	43 2. 
84:.z.c. 44.7761  
The second equation excludes the liver from the region whereas the last 
inequality excludes the heart. 
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Remainder: The "remainder" was assumed to be the total body, minus all 
other organs and regions mentioned above. This region was included to 
account for the essentially uniform distribution of a large fraction of the 
total blood volume in the body. A special source subroutine was prepared 
which allowed the selection of starting coordinates for photon histories 
uniformly throughout the phantom except in the organs and regions included 
explicitly in the model of the circulating blood. 
Calculations of Absorbed Fractions  
Using the model described above, computer calculations were performed for 
the 12 monoenergetic photon energies ranging from 0.01 to 4.0 MeV. In each 
calculation 60,000 photon histories were traced. Tables 6-8 present the 
absorbed fractions of energy for monoenergetic photons sources distributed 
uniformly in the model of the circulating blood. Tables 9-11 present the 
specific absorbed fractions for the same 12 monoenergetic photon sources. 
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mold "dosimetric organs" has not been investigated. 
Summary of Progress 
terminated because of funding problems and not because of insurmountable 
technical problems.
(16) 
Before this method can be applied widely to the experimental determi-
nation of internal exposure conditions, additional research will be 
required. There has been some indication that the thermoluminescence prop-
erties of TLD materials may be changed after contact with organic liquids. 
For example, LiF has been suspended (or surrounded) in organic liquids with 
high hydrogen content to increase the TL response to fast neutrons.
(17,18) 
Puite (19) performed a similar study with CaF
2 (Mn) suspended in organic 
liquids. Spurny and his colleagues (20) studied the effects on TL response of 
suspending LiF in water. The mechanism of the changes in response of TL 
materials in these liquids is not completely clear. The effects on TL 
response of suspending a TLD powder in an organic matrix (such as PAC) to 
During the past year the dosimetry research program has continued in the 
School of Nuclear Engineering and Health Physics at the Georgia Institute of 
Technology. The major objective of this program has been to provide 
research results upon which a useful internal dosimetry system could be 
based. The important application of this dosimetry system will be the 
experimental verification of internal dosimetry calculations such as those 
published by the MIRD Committee 
 
Specific research goals attained will be divided into several catego-
ries to discuss the progress in each area. 
A. The Dosimetric  System:  
The detection system used in this research was the Pate dosimeter 
which derives its name from the mixture of paraffin and 
tetrachlorobenzene. The volumetric dosimeter contains 0.1% to 0.5% 
LiF TLD-100 powder, depending on the size of the organ. The 
chemical and elemental compositions of the mixture for a 0.5% TLD 
concentration are given in Table 1. For the lower concentrations, 
the ratio paraffin-tetrachlorobenzene remains constant. The 
3  
dosimeter has a density of 0.96% + 0.01 g/cm which is very close to 
the density of the MIRD tissue material (0.987 g/cm
3
). 	Table 2 
gives the different interaction coefficients for the Pate + 0.5% 
TLD-100 dosimeter, while Table 3 gives a comparison between these 
coefficients and those of the MIRD tissue. The MIRD tissue is that 
derived by Snyder and his colleagues and is therefore referred to in 
the table as "ORNL tissue" (1 ' 2 ' 3) . 
Fabrication of  Dosimetric Organs  
Fabrication of a dosimetric organ starts by lining the walls of the 
two halves of the plaster bandage mold (see mold fabrication section) 
with aluminum foil to provide easy separation between the mold and the 
organ dosimeter. Preparation of the dosimeter itself requires special 
care to maintain the purity of the TLD powder and the composition of the 
mixture. The TLD powder has a 100-200 Tyler mesh crystal size. This 
crystal size is commercially available and it was chosen to achieve a 
more uniform distribution of the TLD powder in the organic mixture. 
The procedure for preparing the Pate dosimetric organs is as 
follows: paraffin and tetrachlorobenzene are mixed in the specified 
proportions and melted in a beaker at a temperature of about 80 °C. The 
Table 1. General Characteristics of the Pate Organ Dosimeter 
Composition: 















Average Atomic Wt.: 	11.9544 
Number of Electrons Per Gram: 	3.39638E+23 
Effective Atomic Number: 	7.39188 
Average Molecular Wt.: 	11.9544 
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TABLE 2. MASS ATTENUATION AND ABSORPTION COEFFICIENTS FOR PATE + 0.5% TLD - 100 








CO-IERENT INCOHERENT TOTAL 	ATTN. ABSORPTION 
10 49.9416E-01 18.6441E-02 16.7593E-02 53.4620E-01 49.9730E-01 
15 14.4824E01 10.714E-02 18.5822E-02 17.3997E-01 14.5139E-01 
20 5:1.0267E•-02 70.7687E-03 19.3507E-02 65.4542E-02 59.7252E-02 
30 16.4073E-02 37.3817E-03 19.6604E-02 39.8859E-02 17.4296E-C2 
4C 65.6432E-03 23.10310-03 19.3697E-02 23.2449E-02 76.5628E-03 
53 32.1944E-03 15.6335E-03 18.6941E-02 23.6319E-02 47.4419E-03 
50 17.9889E-03 11.3273E-03 18.3b99E-02 21.3015E-02 35.2199E-03 
80 71.900E-04 56.8096E-04 17.3483E02 18.7363E-02 27.5136E-03 
100 35.5278E-0 43.971DE-04 16.4373E-02 17.2313E-02 26.2363E-03 
1:0 10.0018E-34 20.0007E-04 14.6418E-02 14.9418E-02 27.5750E-03 
2Cj 41.3938L-05 11.2968E-04 13.3418E-02 13.4962E-02 29.2590E-03 
300 12.3325E-Oti 49.7472E-05 11.5821E-02 11.6442E-02 31.3487E-03 
400 53.7370E-06 27.5861E-05 10.4323E-02 10.4653E-02 32.3730E-03 
5JO 28.7562E-06 17.4109E-05 96.1302E-03 96.3331E-03 32.9437E-03 
6(..)0 17.4928E-06 11.9412E-05 89.9527E-03 90.0896E-03 33.0751E-03 
800 82.0970E-07 55.3?51E-0 91.190tE-03 81.2646E-03 33.2070E-03 
1000 46.h422E-07 41.5034E-0: 75.2344E-C3 75.2805E-03 33.1003E-03 
44, 44(*****##4444#******4c**44#*.*************M****M* 
*************444444044*****M***********444*4)4.4444* 
Table 3. 	COMPARISON OF PATE +0.5% TL0-100 WITH ORNL TISSUE 
4.);=#***'4***4c*It************************4**4****4c#444 
 **M**4ct****************************************44= 
ENERGY (key) 	t 	PHOTO t 	COHERENT 7: 	INCOHERENT 
10 0.7445 -29.5627 16.6732 
15 7.9975 -23.8439 12.5420 
20 12.5992 -28.2976 9.64 2 5 
30 18.1915 -27.5333 7.1709 
40 21.50b6 -27.0301 6.3313 
50 23.7211 -26.67E0 6.0907 
of 25.3175 -26.4234 6.1066 
80 27.4961 -26.0366 6.4367 
100 26.9495 -25.9176 6.8650 
15.) 31.2396 -25.7934 7.3032 
200 32.7463 -25.8863 8.4042 
300 34.998 2 -25.3177 8.8396 
400 36.8854 -26.8548 e.654e 
500 38.6323 -27.4143 8.1265 
6C3 40.3038 -27.9580 7.3994 
800 43.5048 -24.0235 5.6391 
1000 46.5911 -29.947? 3.7080 
resulting mixture is screened through a 200 Tyler mesh sieve to remove 
unwanted impurities. The beaker is then placed in a 60 °C water bath and 
allowed to cool until the temperature of the Pate compound equals that 
of the bath. At this stage, the Pate is in a semi-liquid, semi-solid 
state, and the TLD powder is added by sprinkling while mixing by hand. 
This manual mixing ensures a uniform distribution of the TLD crystals in 
the organ dosimeter (less than 3.4% variation in the concentration of 
the TLD powder in any part of the organ). The final step consists of 
overfililng the two halves of the plaster bandage mold and joining them 
together while the Pate dosimeter is still hot. After a short cooling 
period, the dosimetric organ is removed from the mold and is ready to be 
placed in the phantom for irradiation. Inspection of this complete 
organ shows good fusion of the two halves. There are no visible boun-
daries and the "fused" organ dosimeter exhibits similar physical 




The above organ fabrication procedure is used for all organs of unit 
density. However, in the case of the lungs, which have a density of 0.3 
g/cm
3
, a different technique is used. After the screened Pate mixture 
has solidified, it is shredded in a food processor. TLD powder is added 
in small samples to the shredded Pate while stirring to obtain a uniform 
distribution of the TLD crystals. The final dosimetric mixture is 
poured in a lung container mold made of fiberglass. Fabrication of 
these containers is described in the section B dealing with the 
preparation of organ molds. 
Once the irradiation of the dosimeter organs is accomplished, they 
are put through a procedure to recover the TLD powder. This procedure 
is described below. 
TLD Powder Recovery Procedure 
Several techniques were investigated for the recovery of the ther-
moluminescent powder for the organic mixture. The following procedure 
was chosen because it left the TLD crystals essentially free of impuri-
ties. 
1. Put the Pate organ in a beaker and add carbon tetrachloride 
(CC1 4
) in a 1:2 ratio. 
2. Heat the mixture to a maximum temperature of 80°C. 
3. Once the Pate has dissolved, pour the mixture (Pate + CC1 4 ) 
through the 200 Tyler mesh sieve. 
4. Place the sieve in three separate dishes containing warm CC1 4 , 
for about 90 sec in each dish. This 3 stage purification should 
dissolve most of the Pate. 
5. Place the sieve in a vacuum funnel and allow the crystals to air 
dry. It takes about 3 minutes for the TLD crystals to dry. 
6. Hold the sieve above the last dish (see step 4 above), and wash 
the TLD crystals with CC1 4 from the wash bottle. 
7. Repeat step 5; this time, the TLD crystals should be left to dry 
completely for about 6 minutes. 
8. Put the TLD crystals into the 2 sieve screening system (3 inch 
diameter, the 100 mesh sieve on top of the 200 mesh sieve) and 
shake until the TLD powder is screened. 
9. Pour the TLD powder on a piece of weighing paper and weigh; 
after weighing, place the TLD powder in a marked stainless 
steel dish for evaluation. 
In the case of the lungs a different procedure for recovering the 
TLD powder without melting the organic mixture was attempted. This 
procedure consisted of screening the TLD powder and reusing the 
shredded Pate. The Pate mixture clogged the sieve and the above proce-
dure had to be used to recover the TLD crystals. 
A study was performed to determine the recovery rate of the TLD 
powder using the above procedures. Several samples were used and the 
data collected indicated that a recovery rate of at least 97% could be 
achieved. The loss of the TLD powder was mainly due to two factors: 
pulverization of the crystals to a size smaller than 200 Tyler mesh and 
adherence to the various pieces of equipment used in the experiment. 
Reading Procedure: 
The reading equipment consisted of a Harshaw TL detector, model 
2000 A, and an automatic integrating picoammeter, model 2000 B. 
The reading characteristics were: 
High voltage: 700 volts 
Preheat temperture: 100 °C 
Heating rate: 5.7 °C/sec 
Reading time: 30 sec 
Maximum temperature 250 ° C 
The electrically vibrated 	powder dispenser was used to measure 
each TLD sample to be read. This dispenser was calibrated using fresh 
TLD powder, and was found to have an accuracy of 3% with the mean weight 
of a dispensed sample being 13.875 mg. A better accuracy could probably 
be achieved for situations involving a few samples, however this 
accuracy was considered acceptable considering the hundreds of samples 
which had to be evaluated in this research. 
Annealing Procedure: 
During each cycle, the TLD powder goes through two annealing proce-
dures: a pre-annealing step before the TLD powder is mixed with the Pate 
compound serves the purpose of restoring the TLD crystals to their 
original charctertistics, and a post-annealing step which is carried 
out after the TLD powder is recovered from the organic mixture. This 
latter step is required because of the instability of the low tempera-
ture peaks. In addition, this procedure ensured that all the TLD 
samples were treated the same way considering the temperature fluctua-
tions that may occur during the recovery procedure. Post-annealing con-
sisted of a period of 10 minutes at a temperature of 100 °C. 
Three experiments were carried out to determine the optimum pre-
annealing procedures. In the first experiment, the TLD powder was 
annealed at 400 °C for 1 hour and at 80 °C for 24 hours with no cooling 
period in between. The second study consisted of an anneal for 1 hour 
at 400 °C and 2 hours at 100 °C with no cooling period, while in the third 
experiment, a cooling period of 15 minutes between the two heatings was 
used. The results obtained with the third annealing method were found 
to be reproducible. In addition, the TLD-100 showed a better 
sensitivity with the third annealing procedure. 
TLD Distribution in Pate  
Several methods of molding were investigated with an objective of 
achieving a uniform TLD crystal distribution in the Pate mixture. The 
first method consisted of melting the Pate in a beaker and adding the 
TLD powder. The resulting mixture was poured into a right cylindrical 
mold "at once", and left to cool in a freezer. The inside of the 
cylindrical mold had a diameter of 5.3 cm and a height of 30 cm. After 
solidification, the Pate-TLD compound was removed from the mold and 
sliced into 13 sections. The thickness and mass of each slice were 
determined before attempting to recover the TLD-100 powder. The data 
obtained in this study are given in Table 4. Slice number 1 corresponds 
to the bottom of the cylinder, whereas slice number 13, is the upper 
portion of the cylinder. The extremely uneven distribution of the TLD-
100 powder in the Pate mixture can be seen clearly in these data. The 
TLD concentration in the Pate can be characterized as following an 
exponential decrease from the bottom to the top of the cylinder. 
The next attempt to obtain a uniform mixture of Pate and TLD 
cyrstals was made using ultrasound. The melted mixture was transferred 
to a beaker. The beaker was placed in a warm water bath which served as 
a conducting medium for the ultrasounds generated by a 300 W. trans-
ducer. The transducer was used to agitate the liquid Pate-TLD mixture 
for periods of more than one hour. In all cases, the TLD cyrstals 
remained on the bottom of the beaker where they had settled initially. 
For this reason, the experiment was terminated and no data were taken. 
To overcome the above problems, a third method was devised. This 
method utilized a layering process which is described below: 
a. melt paraffin and C 5H2C1 4 at a temperature of about 80-
100°C. 
b. pour this mixture through the 200 Tyler mesh screen. 
c. allow the mixture to solidify in a shallow stainless steel 
pan. 














1 2.042 2.042 45.05492 7.51645 16.6829 
2 1.431 3.473 31.57830 0.29480 0.9336 
3 1.552 5.025 39.23465 0.13410 0.3917 
4 1.137 6.162 25.08504 0.03795 0.1513 
5 1.467 7.629 32.37079 0.03720 0.1149 
6 1.082 8.711 23.87346 0.02165 0.0907 
7 1.567 10.278 34.56629 0.02178 0.0360 
8 1.532 11.810 33.79788 0.02650 0.0783 
9 1.972 13.782 43.51380 0.02220 0.0510 
10 1.562 15.644 34.46477 0.01388 0.0402 
11 1.922 17.566 42.41088 0.01012 0.0239 
12 1.455 19.021 32.09712 0.00005 0.0002 
13 1.617 20.638 35.66424 0.01068 0.0299 
Total weight of TLD recovered 8.14735 g 
d. when organ dosimeters are to be formed, break the paraffin-
tetrachlorobenzene material into chunks. 
e. place about 100 g of these chunks in a beaker and remelt at 
about 80-100°C. 
f. screen the TLD-100 crystals through the 100 and 200 Tyler 
mesh screen. 
g 	weigh out the proper amount of the TLD-100 crystals for 
use. 
h. pour a portion of the melted mixture into a 50 ml beaker and 
add the correct amount of TLD powder. Stir the mixture well 
and pour the liquid Pate into another beaker for future 
use. 
i. pour another 50 ml of the melted mixture into the same 
beaker and add the required amount of TLD powder. Pour this 
liquid Pate into the organ mold and allow 10-15 minutes for 
solidification. 
j 	repeat step i, allowing for solidification, until the mold 
is completely filled. 
At the end of the process, the complete Pate molded organ was inspected 
and good joining of the layers was evident. In fact, once the mixture 
had solidified, the individual layers were not identifiable to the 
naked eye. No boundaries were visible and the layered organ dosimeters 
exhibited similar physical characteristics to those molded at one 
pouring. 
A distribution study similar to the one described for the first 
method was performed. In this experiment, the right circular cylinder 
of Pate was cut into 17 slices. Each slice was measured, dissolved and 
the TLD crystals recovered according to established procedures. The 
data from this experiment are shown in Table 5. The mean concentration 
in the 17 slices was 1.086 + 0.470 g of TLD powder. However, close 
inspection of the table indicates a problem with top four slices (slices 
14-17). The high concentration in slice 14 was thought to be due to the 
lack of adherence to the established procedure. That is, the Pate layer 
was not allowed to solidify completely before subsequent layers were 
poured. The mean concentration in slices 1-13 was found to be 1.120 + 
0.216 g of TLD powder. 
The variation of + 20% in the TLD distribution was an improvement 
over that of the previous methods. This technique was very promising 
and with further refinements a + 11% variation was achieved. However, 
when molding large organs, such as the liver, the horizontal distribu-
tion of the TLD crystals suffered and variations of up to + 500% were 
recorded. For this reason, the layer method was found unsatisfactory, 
and other procedures had to be developed to ensure a uniform distribu-
tion of the TLD powder in the organ dosimeter. This led to the molding 
technique described in a previous section (see Fabrication of Dosime-
tric Organs). Two distribution studies were conducted: in the first 
study, the TLD powder was added in one pouring to the Pate mixture, 
while in the second, the TLD powder was sprinkled while mixing. After 
molding and solidification, the samples were cut in chunks in different 
directions. Each pre-weighed chunk was placed in a beaker and the TLD 
powder recovered and weighed. The data from the first study are given 
in Table 6, while the data from the second study are given in Table 7. 
In the latter study, a standard deviation of 3.4% was achieved while, 
for the method when the TLD powder is added in one pouring, the error 















1 0.68 0.68 14.95150 0.19273 1.289 
2 0.88 1.56 19.37895 0.24385 1.258 
3 1.42 2.98 31.28255 0.43510 1.390 
4 1.22 4.20 26.83448 0.35420 1.320 
5 1.72 5.92 38.01695 0.34540 0.909 
6 1.23 7.15 27.21747 0.21915 0.805 
7 1.03 8.18 22.68863 0.24100 1.062 
8 1.42 9.60 31.38180 0.38513 1.227 
9 1.78 11.38 39.23075 0.43495 1.109 
10 1.25 12.63 27.58180 0.20190 0.732 
11 1.12 13.75 24.61440 0.24365 0.990 
12 1.31 15.05 28.8653 0.40120 1.390 
13 1.10 16.16 24.25600 0.26130 1.077 
14 1.77 17.93 38.95190 0.93115 2.391 
15 1.37 19.30 30.30130 0.27295 0.901 
16 1.39 20.69 30.6400 0.11150 0.364 
17 2.98 23.67 65.84770 • 0.16225 0.246 
Table 6. TLD Distribution Using Hand-Mixing and Adding the TLD 
Powder to Mixture in one Batch 
Sample Weight TLD-100 Weight 	 Concentration 
Number (g) (0 	 (%) 
1 36.1 0.28115 	 0.7788 
2 27.1 0.1695 	 0.6255 
3 40.4 0.2880 	 0.7129 
4 34.8 0.2270 	 0.6583 
5 28.4 0.20345 	 0.7164 
6 44.3 0.3095 	 0.6986 
7 44.5 0.3351 	 0.7530 
8 30.6 0.1550 	 0.5082 
9 43.5 0.27685 	 0.6364 
10 38.5 0.2349 	 0.6101 
Average 
Total 368.2g 2.48045 	Concentration 0.6737% 
Table 7. TLD Distribution Using the Hand-Mixing Method and Adding 
TLD Powder by Sprinkling 
Sample Weight TLD-100 Weight Concentration 
Number (g) (g) (%) 
1 81.6 0.19485 0.2388 
2 51.35 0.1251 0.2437 
3 60.7 0.15795 0.2602 
4 51.1 0.12715 0.2488 
5 43.32 0.10180 0.2350 
6 64.3 0.1547 0.2406 
7 72.85 0.18750 0.2574 
8 88.9 0.22965 0.2583 
9 54.45 0.1320 0.2424 
10 55.4 0.1390 0.2509 
Total 623.97 1.5497 
Average concentration 
in the mold } 
0.2484% 
Table 8. Dependence of TLD Response on TLD Concentration 
Sample 
Number 
TLD Concentration TLD Output 
rel. 	units 
1 0.059 63.06 
2 0.220 76.43 
3 0.332 69.01 
4 0.337 75.11 
5 0.413 68.55 
6 0.743 77.18 
7 0.928 75.09 
8 1.052 79.16 
9 1.229 74.89 
10 1.430 73.57 
Mean: 73.21 + 4.88 
was + 11.84%. These findings explain the choice of the present dosime-
tric organ fabrication technique. 
Dependence of TLD Response on Concentration 
Because the TLD concentration in Pate varies from 0.1% to 0.5% 
depending on the size of the organ, a study was initiated to determine 
the effect of concentration on the TLD response. Eleven Pate dosimeters 
were fabricated, using beakers as the molds, for use in this study. 
Each beaker was filled with 130 g of Pate and TLD powder. The TLD 
concentration ranged from 0.06% to 1.43%. Sample number eleven, with a 
TLD concentration of 1.04%, was used as a control. The other samples 
were irradiated individually to the same exposure with gamma-rays, and 
the TLD powder recovered and read. Table 8 presents the data collected 
in this experiment. The mean TLD output (expressed in arbitrary units) 
was 73.21 with a standard deviation of 4.88. This result was within the 
expected range of error. However, it is thought that one source of 
error is the positioning error associated with this experiment. Never-
theless, these data show that there is no noticeable effect on the TLD 
response when the TLD concentration varies from 0.06% to 1.43%. 
Effect of Pate Mixture on TLD Response: 
The mixing of the TLD-100 powder with organic materials may 
change the thermoluminescent characteristics of the phosphor. In-
formation on this possible effect in the literature is negligible, 
if not absent. 	Therefore, it was necessary to investigate the 
effects the Pate compound may have on the TLD crystals. 	Several 
studies of the TLD characteristics were conducted, and the results 
are reported below: 
- Effect on the Glow Curve: 
Pure TLD-100 powder contained in nylon capsules and TLD-100 
powder in Pate were irradiated, and their glow curves were 
Table 9. Effect of Usage on TLD Response 
Number of 
Cycles 
Response of TLD in Pate 
(Arb. 	units) 
Response of TLD in Capsules 
(Arb. 	units) 
0 28.01 
1 24.48 32.35 
2 25.47 31.26 
3 25.62 34.54 
4 25.37 31.25 
5 27.05 32.06 
6 23.91 30.83 
8 23.72 30.02 
12 21.74 30.35 
16 21.26 27.24 
22 24.58 28.77 
Mean 24.32 30.61 
Standard Deviation + 1.77 + 2.08 
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Fig. 1. Glow curve for L 	TLD-100 crystals recovered from the Pate 
dosimeter-. 
obtained (Figure 1.). Comparison of the two sets of glow curves 
showed no noticeable variation or effect. 
- Effect of Usage  on  TLD Response:  
In this experiment, the dependence of the TLD response on 
the number of uses, or the number of cycles it goes through, was 
studied. A sample of the TLD-100 powder was divided in two 
equal parts. One part was used in the Pate mixture, the other 
part was loaded into nylon capsules. Any apparent effect of the 
number of uses on the TLD response could be easily recorded by 
comparing the data obtained from the two different samples. 
One cycle for the TLD-100 powder in capsules was defined as 
pre-annealing, irradiation, post-annealing, and reading. A 
cycle for the TLD-100 powder in Pate was defined as pre-anneal-
ing, mixing with Pate, irradiation, recovery, post-annealing, 
and reading. Both samples were used for 22 cycles, starting 
with cycle 0 for the TLD in capsules and cycle 1 for the Pate 
dosimeter. Cycle 0 was run to ensure an exposure which gave 
reasonable light output for subsequent readings. 	Table 9 
summarizes the data obtained in this study. 	Although the 
relative light output in Pate is less than that obtained for 
irradiations in nylon capsules, the data indicated no effect 
for up to 22 cycles of use. This means, standard deviations, 
and the calculated percent errors were found to be within the 
expected range. 
Effect of Contact Time on TLD Response  
Two experiments were carried out to investigate the dependence 
of TLD response on the time of suspension in the Pate mixture. 
These two experiments were generally similar, except that in the 
first, possible changes in the fading properties of the TLD powder 
were studied, while in the second, the study centered on possible 
effects before irradiation. 
- Fading  
Several sample Pate dosimeters were fabricated for this 
study; half of them were used as controls and the other half 
were irradiated individually one after the other. The TLD 
powder was recovered from the dosimeters and data were taken 
over a period of three weeks. The resulting TL fading was no 
more than 3% which was in agreement with the value quoted in the 
Harshaw data sheet. 
Before Irradiation 
In this investigation, two attempts were made to record any 
change in the TLD response due to contact with the Pate mixture 
before irradiation. In the first study TLD-100 was in contact with 
the Pate mixture for 13 days. In the second, this contact time was 
extended to 22 days. No noticeable effect on the TLD response was 
observed. The standard variation of the data was within the 
expected statistical error. 
Response of TLD-100 Suspended in Grated Pate  (Lungs) 
The object of this study was to compare the response of the TLD 
crystals suspended in grated pate with that of the TLD crystals 
mixed with Pate and then the resulting compound shredded. All 
samples from both molding techniques were irradiated in the same 
manner, and there was no apparent difference in the resulting data. 
However, losses of TLD powder were much higher when the Pate and TLD 
powder were mixed, solidified, and shredded. This loss was thought 
to be due to pulverization of the crystals by the food processor. 
Calibration Curve  
A calibration curve (Figure 2), was obtained for absorbed doses 
between 10 mrads and 6500 rads. All exposures were carried out in a 
water tank in which the absorbed dose as a function of position was 
known accurately. 	Fifteen samples were read for each absorbed 
dose. 	The data, given in Table 10, for this calibration had an 
average standard deviation of 1.4%. The relation of TL output to 
absorbed dose was found to be linear up to almost 1000 rads where 
signs of supralinearity began to appear. Also, because of large 
uncertainties at low doses, it was considered that the lower limit 
of usefulness of the dosimeter was 20 mrads. 
Energy Response:  
The energy response of TLD-100 exposed in air is a known char-
acteristic. The purpose of this investigation is to obtain a TLD 
energy response when the irradiation was carried out in water. 
Irradiation in water simulates the conditions expected when the 
dosimeter was used inside the phantom. This experiment was very 
delicate due to problems encountered in determining precisely the 
photon energy at different depths in a water tank. Pate samples 
were made small to reduce fluctuations dose to changes in photon 
energy as a function of depth in the phantom. Figure 3 shows a 
curve of the energy response of the Pate dosimeter in water. This 
response is very similar to that of TLD-100 in air except for the 
fact that there seems to be a small overresponse at low photon 
energies. 
Table 10. Calibration Curve Data 
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Fig. 2. Calibration curve for LiF TLD-100 crystals used in the Pate 
dosimeter. Calibration performed with Co-60 gamma-rays and 
exposures made inside a water-filled phantom. 
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Fig. 3. Energy response of the LiF TLD-100 crystals used in the Pate 
dosimeter. All exposures made inside a water-filled phantom. 
Errors Associated with the Dosimetric System 
There are three sources of systematic error: non-uniform dis-
tribution of the TLD crystals in the organic mixture, the TLD 
reader-powder dispenser error, and the error associated with the 
TLD reading system. 
The variation in the TLD concentration has been estimated to be 
no more than 3.5% in any part of any organ. Even though this 
variation does not translate automatically to a 3.5% standard devi-
ation in the measurement of the absorbed dose, it was assumed that 
it represents at the most an average value. 
The error associated with the powder dispenser has been estima-
ted to be of the order of 2.9%, which is higher than expected from 
an electrially vibrated dispenser. This large error was thought to 
be due to the fact that thousands of samples had to be read, and 
consequently, errors associated with the powder dispenser had a 
strong influence on the final error associated with the experiment. 
The last source of error was due to the reading system itself, 
including the positioning of the pan containing the TLD powder on 
the tray. Throughout this study, an average standard deviation of 
3% was achieved for doses ranging from 20 mrads to 1000 rads. 
Therefore, and in summary, the total error associated with the 
dosimetric system can be estimated to be about 9.4%. This result 
and the characteristics described in previous sections make the 
Pate dosimeter a suitable choice to perform the necessary internal 
dose measurements. 
B. Preparation of Molds  
To prepare the Pate dosimeter described in A. above it was 
necessary that molds be fabricated which resembled the organs of 
interest as closely as possible. Several techniques were studied 
and much of this work has been described in previous reports. 
Organs for use in this study were fabricated in the following 
manner. A computer routine (22) was used to plot-out cross-
sections of the mathematical phantom at 1 cm intervals along the 
vertical axis of the phantom. Organs, for which organ molds were 
required, were identified and cut out of the printout paper. These 
organ shapes were traced on hardwood boards (1 cm thick). The 
shapes were cut out, assembled, and fabricated to create positive 
replicas of the mathematical organs (see Fig. 4). 
The dosimetry technique suggested by Feher et al. (13) requires 
a negative mold to produce a dosimeter which matches the organ 
shape. Even though the PAC dosimeter these authors described was 
discarded in favor of the Pate dosimeter, a negative mold was still 
required for each organ. A negative mold (or container) was also 
needed for organs which would contain the radioactive source 
material. Fabrication of these source organ containers will be 
discussed also in this section. 
Plaster Bandage Molding 
Several molding techniques were considered including plaster of 
paris - stone casting, vacuum plastic molding, and plaster bandage 
molding. The latter technique was selected because it was inexpen-
sive, was relatively rapid, and the mold properties were superior 




Fig, 4. Wooden models of the mathematical organs. 
The procedure for forming negative organ molds is as follows. A 
hardwood mold was pre-treated with a thin film of silicon lubricant 
to provide easy removal of the plaster mold. Several layers of 
quick-settling plaster bandages* were mixed with water and wrapped 
around the pre-treated mold. 	Bandages were applied to the mold 
until a layer approximately 2 cm thick was formed. 	The plaster 
"cast" was allowed to harden for a short time, at room temperature, 
until it was sufficiently rigid to be cut. Then the cast was cut 
into two pieces for future removal of the organ mold. However, the 
mold was allowed to set-up completely for more than 18 hr., at room 
temperature, with the positive mold still inside to avoid shrinkage 
and assure structural integrity. 
After removal of the positive organ mold the two halves of the 
plaster (negative) mold were rejoined and held together with addi-
tional strips of plaster bandage (see Figure 5). These negative 
molds, produced by the above procedures, were used to form the 
required volumetric dosimeters (see Figure 6). 
Section A of this report indicates a deviation from this proce-
dure when forming the volumetric dosimeter. This change was dic-
tated by the non-uniform distribution of TLD powder when the Pate-
TLD mixture was poured into the plaster organ mold. However, the 
new molding procedure still uses plaster bandage molds produced as 
described above. 
Fiberglass Molding 
Organ replicas also were required to contain radioactive mate-
rials when the organ was assumed to be a "source organ". In this 
*Johnson and Johnson Products, Inc., New Brunswick, New York 08903. 
Fig. 5. Kidney molds. Top: wooden mold and plaster bandage mold, 
Bottom: fiberglass mold and volumetric dosimeter, 
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Fig. 6. Volumetric dosimeters. (top: liver and heart, bottom: kidney and uterus) 
case, plaster bandage molding was not appropriate. A strong, thin, 
lightweight source organ replica was required for this purpose. In 
addition, it was necessary to be able to seal the source organs to 
prevent leakage of the contained radioactive material into the 
liquid-filled phantom (during use) or into the shielded well 
(during storage). 
Fiberglass was selected as a material which met the above cri-
teria. In addition, strips of fiberglass could be laid down over 
the wooden positive organ molds in a fashion similar to the plaster-
bandage molding technique. The resulting fiberglass replica was 
strong, lightweight and was faithful to the organ mold around which 
it was formed. 
Fiberglass organ replicas were formed for the kidneys, lungs, 
liver, bladder, uterus, and stomach. These replicas were fitted 
with lucite openings and screw-plugs to allow easy filling and 
sealing. In most cases, other lucite attachments had to be added to 
the outside of the source organ replicas to allow positive posi-
tioning inside the trunk of the phantom, and to ensure their struc-
tural integrity (see Figure 7). 
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Fig. 7. Wooden and fiberglass molds of the right lung. 
  
C. 	Source Organ Fabrication  
Organs containing radioactive material (i.e., source organs) were 
fabricated for use in this experiment. The radionuclide Co-60 was selected 
for use in the initial experiments for several reasons. First, the radio-
nuclide had a long half-life and decay corrections over the 1 -2 day exposure 
period in each experiment were not required. Second, high energy photons 
emitted in the decay allowed measurements of absorbed dose to organs at 
relatively large distances from the source organ. Third, use of Co-60 
provided a link between these experiments and those of Garry, et al. (5) and 
Mei et al. (6). 
The Co-60 to be used in these experiments was produced by neutron 
activation in the Georgia Tech Research Reactor (GTRR). The substance to be 
irradiated was cobaltous nitrate (Co(NO 3 ) 2 .6 H20) which contained 20.25% of 
the isotope Co-59. This isotope is 100% naturally abundant so the produc-
tion of other isotopes of cobalt was not of concern in the irradiation. 
Other activation products (e.g., nitrogen or oxygen) which might be pro-
duced during the irradiation had short half-lives and were not expected to 
pose any problem. In addition, cobaltous nitrate was selected because the 
compound was readily soluble in water. 
An activity of 10 mCi was selected as appropriate for each source 
organ. This activity was selected because irradiations could be accom-
plished in a reasonable period. At the same time it was felt that this 
level of activity could be handled safely and with a minimum of exposure to 
personnel fabricating the source organs. To produce these levels of acti-
vity the GTRR has to be operated for periods varying between 4 and 8 hours 
depending on the size of the organ. After irradiation the Co-60 was stored 
for 2-4 weeks before source organs were fabricated. This storage period 
allowed for the decay of any short lived radionuclides which may have been 
produced during the irradiation. 
In general, fabrication of all source organs followed the same proce-
dures. Total volumes of solutions, etc. were a function of the source organ 
volume. All steps of the procedure were carried out in a chemical hood 
which contained a shielded sink. In addition, certain steps in the proce-
dure used a small gloveless box placed inside the hood. Procedures for 
source organ fabrication are as follows: 
1. Transfer rabbit from the transport cask to the beta shield in the 
hood. 
2. Insert beta shield in left-hand part of the gloveless box (in the 
bottom of the shielded sink). 	Leave these inside the hood for a 
future survey. 
3. Using tool, open the rabbit and dump out the inner container. 
4. Remove hand bringing out the beta shield containing the rabbit (left 
hand) and the rabbit top and opening tool (in right hand). 
5. Step back to allow a radiation survey. 
6. Grip inner container with tongs and vent it by inserting the large 
hypodermic needle in the top. 
7. Using the needle as a handle, remover the container from the gloveless 
box and place the container on absorbent paper in the corner of the 
sink. 
8. Remove the glove box from the sink but do not remove from the hood. 
9. Place a 500 ml beaker into the sink - upside down. Cover bottom of 
beaker with a small piece of absorbent paper. 
10. Place a 250 ml beaker into the sink. 
11. Using the tongs and the large beaker as a rest, cut open the small 
container. 
12. Place the small container in the 250 ml beaker, remove the hypodermic 
needle. 
13. Step back to allow a radiation survey. 
14. Add to the beaker approximately 150 ml of distilled water. 
15. Allow about 10-15 minutes for the material to dissolve. 
16. Remove capsule from the beaker, use a small piece of absorbent paper 
to contain any possible liquid contamination. Discard both in hot 
waste. 
17. Take a sample of the solution with a pipette and transfer to a beaker 
containing a known amount of distilled water. (The sample taken is 
usually either 0.5 or 1 ml depending on the size of the organ. The 
volume of distilled water is selected based on the desired activity.) 
Wash the pipette repeatedly with water from the beaker. Take 10 - 1 ml 
aliquots from the beaker and transfer to 10 stainless steel plan-
chets. 	Dry the planchets under a heat lamp and count the samples 
before proceeding to fill the source organ container. If activity is 
found to be acceptable proceed with step 18. 
18. Place stand (with funnel) in the bottom of the sink. 
19. Position source organ under the funnel. Make sure the funnel tip is 
inserted partically (3-4mm) into the source organ opening. 
20. Pour the cobalt-60 solution into the source organ. 
21. Pour a gelatin solution (gelatin, water and thymol blue) into the 
beaker which contained the cobalt-60 solution. 
22. Pour this solution into the source organ. 
23. The beaker and funnel may be rinsed into the source organ if the organ 
is not completely full. Move funnel out of the way - be aware of 
liquid drops remaining on the funnel tip. 
24. Seal organ by inserting the threaded plug. CAUTION - This does not 
seal the organ completely since the plug has a small hole in it to 
allow air to escape. Wipe the plug with a small piece of absorbent 
paper to insure the surface is dry and can be sealed. 
25. Seal the plug securely with fiberglass resin and allow it to set-up. 
26. Do a wipe test on the outside of the source organ. 
27. Remove the source organ from the hood using a suitable container and 
place in storage for future transfer to the experimental area. 
This procedure was used for fabrication of the bladder, stomach, 
liver, kidneys, and uterus source organs. The gelatin added in step 21 
transformed the Co-60 solution into a semi-liquid form which was less likely 
to be spread widely over an area if the source organs were fractured vio-
lently. 
Calibration of the source organs consisted in evaluating the 10 
stainless steel planchets (obtained in step 17 of the source organ fabri-
cation procedure) of each source organ. The detection system involved a 
Ge(Li) detector calibrated with a NBS mixed radionuclide standard. Table 11 
gives the activity of each source organ used in this research. Also in-
cluded in this table is the percent error associated with each activity, 
characterized by the coefficient of variation (CV). 
It can be seen from Table 11 that the bladder and the stomach source 
organs) had a relatively high coefficient of variation (compared to the 
other four source organs) associated with their activities. These two 
source organs were the first to be fabricated, and at the time they were 
Table 31. Activities of the Source Organs Used 

















a) C.V. = 100 x Standard Deviation 
mean 
made, a slightly different fabrication procedure was used. This procedure 
included a variation in step 17 from the procedure given above. This 
variation consisted of taking sample from the highly radioactive solution 
with a pipette, and dropping approximately 0.05 ml of the sample in each 
stainless steel planchet. This resulted in two types of errors: the 
inability to measure the 0.05 ml aliquot within certain limits of accuracy, 
and an increase of the detector's percent dead time when reading the high 
activity in each planchet. 
The activities of the other four source organs were calculated within 
acceptable limits of accuracy. Their average coefficient of variation is 
2.86%, which brings the total average coefficient of variation for all six 
source organs to 5.24%. 
D. 	Results  
Phantom Preparation:  
Because of the high source organs activities involved, special mea-
sures were taken to comply with the federal and local regulations concerning 
the handling of radioactive materials. For this reason, the phantom Mr. 
ADAM, was placed in a shielded room, and surrounded with additional shield-
ing to reduce the radiation levels outside the room. The phantom was 
assembled, with the bone region in place. The head and the legs tissue 
regions were filled with water, while the trunk region was partially filled 
to allow for positioning of the various target and source organs. 
In-phantom measurements were made for six different source organs, 
• 
namely the stomach, bladder, liver, uterus, left kidney, and right kidney. 
Two absorbed dose measurements were taken for each of these source organs, 
except for the left kidney, which was used only once as a source organ. 
The loading order of the target and source organs in the phantom 
varied from one source organ to another. This order was selected to limit, 
as much as possible, human exposure to radiation, considering that the 
source organs had to be handled by hand. The average time of loading and 
unloading a source organ was approximately 45 sec. The phantom loading 
procedure is given in Table 12 for each source organ used in this research; 
the source organ is underlined to point out its order of loading. 
Once all the target and source organs were loaded, the trunk was 
completely filled with water. Then, the head was positioned on top of the 
trunk base. The time of irradiation for each measurement was set such that 
the TL reading of the target organ expected to receive the least amount of 
Table 12. 	Irradiation Times for the Absorbed 
Dose Measurements. 
Source Organ 
Irradiation Time 	(hrs) 
Measurement-1 Measurement-2 
Bladder 22.75 24.55 
Left Kidney 25.17 
Right Kidney 19.50 14.42 
Liver 23.92 19.27 
Stomach 24.06 20.92 
Uterus 22.38 21.24 
exposure would be statistically acceptable. Table 13 gives the average time 
of irradiation for each source organ. The data presented in this chapter 
were taken over a period of two weeks. 
Results of Measurements  
After the irradiation is completed, the organs are removed in a 
reverse order as they were loaded. The soure organ is taken back immedi-
ately to the storage room to avoid any unwanted irradiation of the target 
organs. Each target organ was cut in small chunks to speed up the recovery 
of the TLD powder, following the procedure described in the preceding 
chapter. Then, each organ's TLD powder was post-annealed for 10 minutes at 
100 °C, after which it was ready to be read. Before each organ's evaluation, 
the sensitivty of the TLD reader was checked and recorded to allow for 
future correction of the data. This correction was needed because, even 
after the TLD crystals are recovered, they still contain invisible amount of 
Pate. 	Therefore, when reading these crystals, the organic impurities 
evaporate and deposit on the filter of the photomultiplier tube. 	This 
deposition leads to a decrease of the sensitivity of the TLD reader over 
time. However, this loss of sensitivity can be estimated using the 14 C 
 light source of the TLD reader, which results in the determination of a 
correction factor relative to the condition of the TLD reader when the 
calibration curve of the TLD powder was generated. This correction factor 
was then applied to the TL reading of each target organ. 
Ten readings were taken for each target organ. With the resulting 
mean, the average absorbed is determined by using the calibration curve and 
its characteristic equation, given in chapter III. The corresponding "S" 
factor is calculated using the following equation: 
(r 2 ‹- r 1
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Table 13. Loading Sequence of the Organs in Mr. ADAM 







right kidney, left kidney, liver, right lung, 
BLADDER, uterus, left lung, and heart. 
uterus, right kidney, liver, right lung, 
LEFT KIDNEY, left lung, and heart. 
uterus, left kidney, liver, left lung, RIGHT  
KIDNEY, right lung, and heart. 
uterus, right kidney, left kidney, left lung, 
LIVER, right lung, and heart. 
uterus, right kidney, liver, right lung, 
left kidney, STOMACH, left lung, and heart. 
right kidney, left kidney, liver, right lung, 
UTERUS, left lung, and heart. 
where, A l is the soruce organ activity given in Table 11, in pCi, and t is 
the irradiation time, in hrs. 
The experimental "S" factors for the various source-organ configura-
tions are given in Table 14 through Table 19. 
Theoretical Results  
To calculate the absorbed fractions using the MIRD technique, the 
computer code ALGAM (described in chapter II) had to be adapted to simulate 
the experimental conditions. This adaptation was made possible by: 
1. incorporating the mathematical equations which define the 
experimental phantom, Mr. ADAM, in place of those defining the 
MIRD phantom; and by 
2. changing the program size of the code to accommodate the larger 
number of media (six) that constitute Mr. ADAM. The chemical 
composition of all these six media was specified in the input data 
file of the code. 
The code was run for each source organ, using 60,000 photon histories. 
The resulting "S" factors were calculated as follows: 
(1) 	+ 02 
(I)
2 
r 2 - r l ) = Al 1 
In the case of 60Co source organs which were used in this research, 
A l 
= 2.503 g-rad/PCi-hrs for photon energies of 1.173 MeV, 
A
2 
= 2.842 g-rad/oCi-hrs for photon energies of 1.332 MeV. 
The calculated "S" factors are given in Table 14 through Table 19. 
Table 14. Comparison Between Calculated and Measured S Factors for a 



























































a C. V. is the coefficient of variation of the S Factor 
Calculated S Factor - Measured S Factor 
b Percent Variation = 	 x 100 Calculated S Factor 
Table 15. Comparison Between Calculated and Measured S Factors for a 
Uniformly Distributed Cobalt-60 Source in the Left Kidney. 
Target Mass of Calculated C. 	V.
a 
Measured Percent 
Organ Organ (g) S Factor (%) S Factor Variationb 
Heart 552 .1251E-04 7.99 .9627E-05 +23.03 
Left Kidney 125 .2469E-02 1.26 
Right Kidney 125 .5787E-04 8.05 .4295E-04 +25.78 
Liver 1683.6 .2670E-04 3.20 .1962E-04 +26.50 
Left Lung 504.3 .1474E-04 7.44 .1304E-04 +11.53 
Right Lung 504.3 .7224E-05 10.63 .5259E-05 +25.82 
Uterus 73.6 .2523E-04 14.21 .2209E-04 +12.45 
a C. V. is the coefficient of variation of the S Factor 
b Percent Variation = Calculated S Factor - Measured S Factor x 100 
Calculated S Factor 
Table 16. Comparison Between Calculated and Measured S Factors for a 














Heart 552 .1492E-04 7.49 .1259E-04 +15.62 
Left Kidney 125 .6363E-04 7.71 .4244E-04 +33.30 
Right Kidney 125 .2410E-02 1.28 
Liver 1683.6 .1087E-03 1.68 .8485E-04 +21.94 
Left Lung 504.3 .7897E-05 10.80 .7595E-05 +3.82 
Right Lung 504.3 .1828E-04 7.24 .1512E-04 +17.29 
Uterus 73.6 .3703E-04 13.12 .2373E-04 +35.92 
a C. V. is the coefficient of variation of the S Factor 
b Percent Variation = Calculated S Factor - Measured S Factor x 100 
Calculated S Factor 
Table 17. Comparison Between Calculated and Measured S Factors for a 
Uniformly Distributed Cobalt-60 Source in the Liver. 
Target
a 
Mass of 	Calculated 	C. V. 	Measured 	Percent 
Organ 	 Organ (g) S Factor (%) S Factor Variation b 
Heart 	 552 	 .2516E-04 	5.74 	.2842E-04 	-12.96 
Left Kidney 	125 	 .2689E-04 	11.91 	.2058E-04 	+23.47 
Right Kidney 	125 	 .9317E-04 	6.38 	.9026E-04 	+3.12 
Liver 	 1683.6 	.4221E-03 	8.02 	 - 	 - 
Left Lung 	 504.3 	.1145E-04 	8.51 	.1344E-04 	-17.38 
Right Lung 	504.3 	.4086E-04 	4.82 	.4191E-04 	-2.57 
Uterus 	 73.6 	.1604E-04 	18.56 	.1378E-04 	+25.75 
a C. V. is the coefficient of variation of the S Factor 
b Percent Variation 
Calculated S Factor - Meaured S Factor x 100 
= 	- - Calculated S Factor 
Table 18. Comparison Between Calculated and Measured S Factors for a 













Heart 552 .2609E-04 5.68 .1685E-04 +35.42 
Left Kidney 125 .8206E-04 6.69 .5989E-04 +27.02 
Right Kidney 125 .2649E-04 10.44 .1903E-04 +28.16 
Liver 1683.6 .3661E-04 2.80 .2516E-04 +31.28 
Left Lung 504.3 .3088E-04 5.44 .2504E-04 +18.91 
Right Lung 504.3 .1109E-04 8.50 .8540E-05 +22.99 
Uterus 73.6 .2072E-04 14.44 .1554E-04 +25.00 
a C. V. is the coefficient of variation of the S Factor 
Calculated S Factor - Measured S Factor x 100 
b Percent Variation = - • - Calculated S Factor 
Table 19. Comparison Between Calculated and Measured S Factors for a 
Uniformly Distributed Cobalt-60 Source in the Uterus. 
Target 	 Mass of 	Calculated 	C. V.
a 
	Measured 	Percent 
Organ Organ (g) S Factor (%) S Factor Variation 
Heart 	 552 	 .3495E-05 	15.23 	.3043E-05 	+12.93 
Left Kidney 	125 	 .2559E-04 	11.39 	.2316E-04 	+9.50 
Right Kidney 	125 	 .3000E-04 	10.68 	.2358E-04 	+21.40 
Liver 	 1683.6 	.1771E-04 	3.92 	.1228E-04 	+30.66 
Left Lung 	 504.3 	.3119E-05 	15.98 	.3263E-05 	-4.62 
Right Lung 	504.3 	.2963E-05 	15.86 	.2735E-05 	+7.69 
Uterus 	 73.6 	.3833E-02 	1.33 
a C. V. is the coefficient of variation of the S Factor 
Calculated S Factor - Measured S Factor 
b Percent Variation = 	 x 100 
Calculated S Factor 
E. Discussion of Results 
Error Estimate: 
There are seven possible sources of errors which are related to the 
measurements of absorbed doses. These errors arise from: 
1. the Pate dosimeter; 
2. the TLD reading system; 
3. the molding technique used to fabricate the dosimetric organs; 
4. the activity in each source organ; 
5. the positioning of the different source and target organs; 
6. the irradiation time; and 
7. the statistical evaluation inherent in the dose measurements 
themselves. 
The first two sources of errors were discussed in great detail in 
section A. The combined error from both the Pate dosimeter and the TLD 
reading system was estimated to be at the most 9.4%. 
The error associated with the molding technique can be evaluated by 
comparing the dimensions of the wooden organs (the equations describing 
these wooden replicas are given in Appendix I) with those of the dosimetric 
and source organs. Several investigations were made to study the reprodu-
cibility of the plaster bandage mold, and its effect on the shape and size 
of the molded organs. The results indicated that if the plaster bandage 
mold is rigid enough (made of several layers of plaster bandage), the 
variation of the dimensions of the molded organs is no more than 1%. 
The activity of each source organ was given in Table 11, including the 
error associated with each activity. The value of this error varies from 
one source organ to another. However, to simplify the estimate of a total 
error for the absorbed dose measurements, an average uncertainty of the 
activity in all source organs was computed and evaluated to be of the order 
of 5.24%. 
The error related to the positioning of the different source and 
target organs was reduced to a neglibile value by using fixed supports to 
hold the organs in Mr. ADAM. These supports remained in the phantom during 
the entire period the absorbed dose measurements were made. The placement 
of the various organs using the supports altered the initial mathematical 
equations describing the positioning of these organs, however, all changes 
were included in the final equations given in Appendix I. 
The error associated with the irradiation time is also almost nil. 
This is due to the fact that most irradiation times for the measurements 
were of the order of 20 hours, while the period of loading and unloading a 
particular source organ is no more than 90 seconds. Therefore, any uncer-
tainty on the irradiation time is assumed negligible. 
Finally, the statistical error inherent in the absorbed dose measure-
ments themselves can be evaluated in terms of the distribution of the data 
for each in-phantom irradiation. A standard deviation was calculated for 
each target organ-source organ configuration. Two measurements were made 
for each source organ, except for the left kidney, and the average coeffi-
cient of variation for all target organs was approximately 2.5%. In the 
case of the left kidney source organ experiment, the average coefficient of 
variation was of the order of 4%. To conclude this paragraph on the 
statistical error, it should be noted that the corresponding coefficient of 
variation depends on all the other six sources of errors discussed pre-
viously. 
Therefore, the average percent error for the absorbed dose measure-
ments can be computed in two steps: first, by adding the coefficients of 
variation of all independent errors, and second by applying the square root 
of the sum of squares method to include the dependent errors. Using this 
rule, the average percent error is at the most 16%. 
Comparison of Calculated and Measured Absorbed Doses  
Comparison of calculated and measured "S" factors for 6 target 
organs-7 target organs configurations were given in Table 14 through Table 
19. Without considering the experimental error, it can be seen from these 
tables that: 
1. All coefficients of variation (CV) are less than 25%. (the level 
of rejection of the Monte Carlo data set by the MIRD Committee), 
and therefore, all calculated "S" factors are statistically 
acceptable; and 
2. the calculated "S" factors are generally higher than the measured 
"S" factors, as indicated by the percent variation data. 
However, this last statement becomes invalid when one takes into 
account the experimental uncertainty. This is shown in Table 20 which gives 
the average percent variation between calculated and measured "S" factors, 
and the percent error of the measurements for each source organ experiment. 
The average coefficient of variation and the average percent variation were 
determined for each source organ by computing the mean of the coefficients 
of variation (C.V.) and the percent variations for the corresponding target 
organs, respectively (see Table 13 through Table 19). The calculation of 
the percent error of the measurements was based on the error analysis 
discussion presented in the preceding section. 
Table 20. Error Estimates and Percent Variation of the "S" 
Factors Data for Each Source Organ Study. 
Source Organ Calculated 
C.V. 	(%) 
"S" Factorsa 
 % Variation 
Experimental 
% Error 
Bladder 15.08 + 11.37 20.55 
Left Kidney 8.59 + 20.85 18.23 
Right Kidney 8.01 + 21.32 12.23 
Liver 9.32 + 	3.24 11.18 
Stomach 7.70 + 26.97 20.55 
Uterus 12.80 + 12.92 12.63 
a) See data tables for the definition of the % Variation 
From Table 20, the data indicate the existence of an agreement between 
calculated and measured absorbed doses for all 6 source organ studies. 
However, this agreement is in "one direction" because there is a slight 
indication that the Monte Carlo calculations may overestimate internal 
absorbed doses by few percentage points. This result applies also to two 
previous attempts to verify the MIRD internal dose calculations. In fact, 
after reanalysis of the data reported by Garry et al. (Ga74) and Mei et al. 
(Me75), it was found that in the majority of the soure organ-target organ 
configurations, the calculated absorbed fractions were a little higher than 
the measured absorbed fractions. Therefore, it can be said that the MIRD 
method may be a little "conservative" in calculating internal absorbed 
doses. If this is the case, we know at least that by using the Monte Carlo 
data correctly, human life was not endangered by under-estimating the 
absorbed doses. 
